Aiforia Technologies has launched a new CE-IVD marked clinical AI solution for lymph node metastasis detection.
The Aiforia Lymph Node Metastasis AI model supports the detection and quantification of metastases of breast cancer, melanoma, and colorectal cancer in lymph nodes from whole slide images. It has been developed in collaboration with the University of Bern.
Lymph node screening is one of the most labor-intensive steps in cancer staging. A single case may require the pathologist to review a multitude of slides under significant time pressure. Aiforia's AI model speeds up the review by providing tools and features that enable rapid navigation to relevant regions within the slides. This enhances workflow efficiency, saving up to 40% of pathologist’s time.
Jukka Tapaninen, CEO of Aiforia commented: “We are proud to launch a new CE-IVD marked AI solution compliant with the IVDR, this time in collaboration with the University of Bern. This AI solution assists pathologists in the time-consuming task of identifying metastases and helps ensure none goes undetected. It delivers substantial time savings and improves the consistency in the diagnostic workflow.”